Alfacalcidol

C₂₇H₄₄O₂

400.64

MFCD00868328

329770599

NA.24

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the authority of the issuing pharmacopoeia. For further information and support please go to the website of the issuing pharmacopoeia. Alfacalcidol is an active metabolite of vitamin D, used as a vitamin supplement due to it longer half-life. It is found to be effective in regulating calcium balance/bone metabolism.

Alfacalcidol may be used as an analytical reference standard for the quantification of the analyte in bulk and tablet dosage forms using spectrophotometric technique.

Synthetic vitamin D₃ analog that is metabolized to 1,25-dihydroxycholecalciferol. Inhibits bone resorption and stimulates bone formation. Supresses parathyroid hormone secretion by bovine parathyroid cells.

Please find SDS provided by EDQM here..

Sales restrictions may apply.

100

synthetic

pharmaceutical primary standard

EP

solid

EDQM

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

pharmaceutical (small molecule)

neat

−20℃

CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C3\C[C@@H](O)C[C@H](O)C3=C

1S/C27H44O2/c1-18(2)8-6-9-19(3)24-13-14-25-21(10-7-15-27(24,25)5)11-12-22-16-23(28)17-26(29)20(22)4/h11-12,18-19,23-26,28-29H,4,6-10,13-17H2,1-3,5H3/b21-11+,22-12-/t19-,23-,24-,25+,26+,27-/m1/s1

OFHCOWSQAMBJIW-AVJTYSNKSA-N

human ... VDR(7421)

Unit quantity: 5 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

GHS06

Danger

H300

P301 + P310 + P330

Acute Tox. 1 Oral

6.1A - Combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials

WGK 3